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I. Introduction 
The legalization of marijuana in many states may bring with it 
additional dangers to a segment of the United States population. If 
left unaddressed, marijuana consumption by individuals who have a 
predisposition for developing schizophrenia may lead to an increase in 
the development and the severity of the disease, especially since 
individuals with schizophrenia sometimes self-medicate with mari-
juana (regardless of its legality in their respective states) due to a 
false perception that it helps them cope with the symptoms.1 That 
perception is even more troubling because marijuana has been shown 
to exacerbate schizophrenia in individuals who have developed the 
disease and to increase the likelihood of disease development in indi-
viduals who have predispositions to the disease.2 Numerous studies 
discuss a connection between marijuana use and schizophrenia 
development.3 The majority of these studies conclude that marijuana 
 
1. See Andrei Szoke et al., Association Between Cannabis Use and Schizotypal 
Dimensions — A Meta-Analysis of Cross-Sectional Studies, 219 PSYCHIATRY 
RES. 58, 58–66 (2014). 
2. Id. at 58–59. 
3. See Sven Andréasson et al., Cannabis and Schizophrenia: A Longitudinal 
Study of Swedish Conscripts, 330 LANCET 1483, 1483 (1987); see also 
Michael T. Compton et al., Association of Pre-Onset Cannabis, Alcohol, 
and Tobacco Use with Age at Onset of Prodrome and Age at Onset of 
Psychosis in First-Episode Patients, 166 AM. J. PSYCHIATRY 1251, 1255 
(2009); Louisa Degenhardt & Wayne Hall, Is Cannabis Use a Contributory 
Cause of Psychosis?, 51 CAN. J. PSYCHIATRY 556, 563 (2006); see Stephen 
M. Eggan et al., Reduced Cortical Cannabinoid 1 Receptor Messenger RNA 
and Protein Expression in Schizophrenia, 65 ARCHIVE GEN. PSYCHIATRY 
772, 773 (2008); Szoke et al., supra note 1, at 59; Paola Casadio et al., 
Cannabis Use in Young People: The Risk for Schizophrenia, Passing the 
Knife Edge in Adolescence: Brain Pruning and Specification of Individual 
Lines of Development, 35 NEUROSCIENCE AND BIOBEHAVIORAL REV.S 1779, 
1779 (2011); A. Eden Evins et al., Does Using Marijuana Increase the Risk 
for Developing Schizophrenia, 74 J. CLIN. PSYCHIATRY e8 (2013) [hereinafter 
Evins 2013]; Nikie Korver et al., Symptomatology and Neuropsychological 
Functioning in Cannabis Using Subjects at Ultra-High Risk for Developing 
Psychosis and Healthy Controls, 33 AUSTL. & N. Z. J. OF PSYCHIATRY 230, 
231 (2010); A. Eden Evins et al., The Effect of Marijuana Use on the Risk 
for Schizophrenia, 73 J. CLIN. PSYCHIATRY 1463, 1465 (2012) [hereinafter 
Evins 2012]; see John Witton, Cannabis Use and Physical Mental Health, in 
A CANNABIS READER: GLOBAL ISSUES AND LOCAL EXPERIENCES, 117, 128 
(Sharon Rodner Sznitman et al. eds., Monograph Ser. No. 8, 2008), 
http://www.emcdda.europa.eu/attachements.cfm/att_53398_EN_emcdda-
cannabis-mon-vol2-ch6-web.pdf; Marla Paul, Teen Marijuana Use Linked 
with Schizophrenia, FUTURITY (Jan. 3, 2014), http://www.futurity.org/teen-
marijuana-abuse. 
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use may trigger schizophrenia in those who are predisposed to the 
disease and may increase its severity because marijuana tends to harm 
underdeveloped areas of the brain that are of particular concern for 
individuals with schizophrenia or predispositions to the disease.4 
Therefore, states that legalize marijuana should take precautions to 
help decrease this harmful effect. Additionally, Congress should 
consider developing federal regulations to help protect citizens from 
the dangers this drug presents to individuals predisposed to devel-
oping schizophrenia, especially when used at a young age. 
In Part II, this Article will present a brief overview of marijuana’s 
effects on a user’s psyche. Part III will present some of the triggers 
and symptoms of schizophrenia. Next, Part IV of this Article will 
explain the connection between marijuana use and schizophrenia 
development, demonstrating that widespread regulation is vital to 
protect the small proportion of the population that will develop 
schizophrenia from marijuana use. This Part will also explain that 
such regulation is necessary even if it will temporarily restrict the 
drug’s use by those who will not ultimately face the threat of 
developing this psychological condition. In Part V, this Article will 
discuss two precautions that lawmakers should take when legalizing 
marijuana. First, states should only legalize marijuana for people who 
are at least twenty-five years old or who have been cleared by a 
psychologist.5 Second, schizophrenics should have restricted access to 
marijuana regardless of their age because the drug exacerbates 
psychosis and may negatively interact with antipsychotic medi-
cations.6 
II. Marijuana and the History of Its Legalization 
Marijuana refers to dried leaves, flowers, stems, and seeds from 
Cannabis sativa, a plant that contains the psychoactive chemical 
delta-9-tetrahydrocannabinol (THC).7 When a user smokes marijuana, 
“THC quickly passes from the user’s lungs into the bloodstream.”8 
Acting on specific molecular targets on brain cells called cannabinoid 
receptors, the user’s blood cells carry the chemical to his or her brain.9 
 
4. Szoke et al., supra note 1, at 58–66; see also sources cited supra note 3. 
5. Casadio et al., supra note 3, at 1781. 
6. Treffert, Marijuana Use in Schizophrenia: A Clear Hazard, 135 AM. J. 
PSYCHIATRY 1213–15 (1978), available at http://www.ncbi.nlm.nih.gov
/pubmed/29496. 
7. DrugFacts: Marijuana, NAT’L. INST. ON DRUG ABUSE, http://www.drugab
use.gov/publications/drugfacts/marijuana (last updated Aug. 2017). 
8. Id. 
9. See id. 
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Marijuana affects the central nervous system and can cause feelings of 
happiness and calm or feelings of paranoia and anxiety.10 Other effects 
include an altered perception of time and distance, impaired 
judgment, unsound decision-making, loss of coordination, slowed 
reaction time, sleepiness, and trouble thinking.11 
Marijuana is the most commonly used illegal drug in the United 
States.12 Approximately one in ten adult Americans used the drug 
within the past year.13 Nearly one-third of the United States 
population has used marijuana at least once.14 Laws regarding the use 
and possession of marijuana have changed in recent years and many 
states have legalized the drug for medicinal or recreational use.15 
Twenty-nine states and the District of Columbia have passed laws 
legalizing marijuana in some form, either for medical use, recreational 
use, or both.16 
Many people believe that federal and state governments should 
legalize marijuana because of its potential economic benefits.17 
Harvard economist Jeffrey Miron calculated that if federal and state 
governments legalized marijuana, both would experience significant 
savings.18 Federal, state, and local governments would save 
approximately $8.7 billion per year in law enforcement costs.19 In  
10. See id. 
11. Id. 
12. What is the Scope of Marijuana Use in the United States?, NAT’L INST. OF 
DRUG ABUSE, https://www.drugabuse.gov/publications/research-reports/ma
rijuana/what-scope-marijuana-use-in-united-states (last updated Aug. 2017). 
13. Aria Hangyu Chen, One in Eight US Adults Says They Smoke Marijuana, 
Poll Says, CNN (Aug. 8, 2016), http://www.cnn.com/2016/08/08/
health/marijuana-use-doubles-gallup- poll/index.html. 
14. Itai Danovitch, Sorting Through the Science on Marijuana, 43 MCGEORGE 
L. REV. 91, 91 (2012). 
15. Charlie Tetiyevsky, Where Is Marijuana Legal In The U.S.A.? The 
Definitive Guide To Weed Laws By State, HERB (Nov. 15, 2017), 
https://herb.co/marijuana/news/where-is-marijuana-legal-united-states.. 
16. Alaska, California, Colorado, the District of Columbia, Maine, 
Massachusetts, Nevada, Oregon, and Washington have legalized marijuana 
for recreational use. Arizona, Arkansas, Connecticut, Delaware, Florida, 
Hawaii, Illinois, Maryland, Michigan, Minnesota, Montana, New Hampshire, 
New Jersey, New Mexico, New York, North Dakota, Ohio, Pennsylvania, 
Rhode Island, Vermont, and West Virginia have legalized medical 
marijuana. See Melia Robinson and Skye Gould, This Map Shows Every 
State That Legalized Marijuana on Election Day, BUS. INSIDER (Nov. 9, 
2009), http://www.businessinsider.com/where-is-marijuana-legal-2016-11. 
17. David Sheff, Marijuana Should Be Legal, But . . . , TIME (Aug. 4, 2014), 
http://time.com/3079707/marijuana-legalization-teens-health. 
18. Id. 
19. Id. 
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addition, marijuana taxation would raise approximately $6.2 billion 
per year if the government taxed the drug at a rate similar to alcohol 
and tobacco: an amount that would allow the federal government to 
obtain an extra $13.9 billion per year in tax revenues.20 Other 
potential benefits of marijuana legalization include reduced crime and 
positive medicinal effects for those suffering with certain physical 
conditions.21 Opponents of marijuana legalization cite possible 
concerns with addiction, mental health, and physical health.22 Spe-
cifically, opponents point to the potential for higher rates of lung 
cancer and birth defects as reasons not to legalize marijuana.23 
III. Schizophrenia 
Schizophrenia is a chronic, severe, and debilitating brain disease 
that affects approximately one percent of the United States pop-
ulation ages eighteen and older in a given year.24 The potential devel-
opment and worsening of schizophrenia also presents25 an argument 
against marijuana’s unrestricted legalization. Schizophrenia can cause 
deterioration in thinking, disturbances in perception, and impairments 
of social function.26 Positive symptoms of schizophrenia include hallu-
cinations, delusions, thought and movement disorders, a monotonous 
voice, and a motionless face.27 Negative symptoms include social with-
 
19. Sheff, supra note 17. 
20. Id. 
21. See Robert G. Morris et al., The Effect of Medical Marijuana Laws on 
Crime: Evidence from State Panel Data, 1990-2006, 9 PLOS 1, 4 (Mar. 26, 
2014), http://journals.plos.org/plosone/article/file?id=10.1371/journal.po
ne.0092816&type=printable; Wynne Armade, Marijuana: Health effects of 
recreational and medical use, HARV. MED. SCHOOL (Aug. 19, 2016), 
https://www.health.harvard.edu/blog/the-health-effects-of-marijuana-from-
recreational-and-medical-use-2016081910180. 
22. Stuart Gitlow, Marijuana Legalization is a Risk Not Worth Taking, CNN 
(July 30, 2014), http://www.cnn.com/2014/07/30/opinion/gitlow-mariju
ana-use. 
23. Marcus Wohlsen, Calif. regulators warn of pot’s cancer capability, SAN 
DIEGO UNION-TRIB. (July 4, 2009), http://www.sandiegouniontribune
.com/sdut-us-marijuana-cancer-070409-2009jul04-story.html. 
24. See What is Schizophrenia, THE NAT’L. INST. OF MENTAL HEALTH (Feb. 
2016), http://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml; 
Schizophrenia-Fact Sheet, TREATMENT ADVOC. CTR. (Aug. 13, 2008), 
http://www.treatmentadvocacycenter.org/evidence-and-research/learn-
more-about/25-schizophrenia-fact-sheet. 
25. What is Schizophrenia, supra note 24. 
26. See id. 
27. Id. 
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drawal, the inability to make decisions, and a lack of motivation and 
emotion.28 Both positive and negative symptoms typically begin be-
tween ages sixteen and thirty.29 A person rarely develops the disease 
after age forty-five.30 The most common age of schizophrenia onset is 
twenty-seven for a female and twenty-five for a male.31 
Schizophrenia treatments include antipsychotic medication, 
psychosocial treatment, rehabilitation, cognitive behavior therapy, 
and self-help groups.32 These treatments may help to relieve many 
symptoms of the disease, but most people with schizophrenia suffer 
from symptoms their entire lives.33 Schizophrenics attempt suicide 
more often than the general population, and approximately ten per-
cent die by suicide.34 Studies also show that individuals diagnosed 
with this disease are four times more likely to engage in violent con-
duct—though rates of violence can be far higher for non-schizophrenic 
individuals who use drugs.35 
Medical experts believe that several factors can cause schiz-
ophrenia.36 Foremost, experts have identified a genetic component to 
developing schizophrenia because of a recent study involving 28,799 
schizophrenic patients and because of the disease’s prevalence among 
those individuals with affected relatives.37 Other possible causes of 
schizophrenia include the malfunction of a gene that creates certain 
chemicals in the brain, an imbalance of dopamine and glutamate, and 
environmental triggers.38 
 
28. Id. 
29. See Schizophrenia In-Depth Report, N.Y. TIMES (2008), http://www.nyt
imes.com/health/guides/disease/schizophrenia/print.html. 
30. Id. 
31. Id. 
32. What is Schizophrenia, supra note 24. 
33. See id. 
34. See Schizophrenia In-Depth Report, supra note 29. 
35. Candice T. Player, Involuntary Outpatient Commitment: The Limits of 
Prevention, 26 STAN. L. & POL’Y REV. 159, 192 (2015) (citing Jeffrey W. 
Swanson, Mental Disorder, Substance Abuse, and Community Violence: An 
Epidemiological Approach, in VIOLENCE AND MENTAL DISORDER 101 (John 
Monahan & Henry J. Steadman eds., 1994)). 
36. See, e.g., Nancy A. Melville, ‘Landmark’ Study Identifies Genetic Link to 
Schizophrenia, MEDSCAPE (2016), http://www.medscape.com/viewart
icle/858062; see also Lindsay Stafford Mader, Cannabis and Schizophrenia, 
99 THE J. OF THE AM. BOTANICAL COUNCIL 46, (2013). 
37. Melville, supra note 36; see also Mader, supra note 36. 
38. Mader, supra note 36. 
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IV. Connection Between Marijuana and Schizophrenia 
and the Implications of Marijuana Legalization on 
Schizophrenia 
Unfortunately, the effects of marijuana use on individuals with 
diagnosed or undiagnosed schizophrenia are not always at the 
forefront of the marijuana-legalization debate.39 This may be because 
schizophrenia is not a widespread psychological illness or because the 
effect of marijuana use by schizophrenics is not widely known.40 
Nevertheless, the legalization debate should consider the drug’s avail-
ability to schizophrenics and individuals who have a predisposition for 
developing the disease. Because carefully crafted marijuana laws could 
prevent many of marijuana’s harmful effects on people who are sus-
ceptible to this psychological disorder, legislation that is conscious of 
these problems could decrease schizophrenia’s harmful effects. 
a. Introduction to the Connection Between Marijuana Use and 
Schizophrenia Development 
Many individuals may perceive marijuana as a harmless recre-
ational drug, but its use can cause harmful results.41 For instance, 
marijuana can result in physiological and psychological effects similar 
to symptoms that schizophrenics experience, such as visual illusions, 
paranoia, mood alterations, and memory defects.42 The research 
regarding marijuana’s impact on schizophrenia includes epidem-
iological studies finding marijuana use to be associated with devel-
oping schizophrenia, even after the studies controlled for several other 
factors.43 These studies conclude that a healthy person with no 
schizophrenia risk factors is unlikely to develop the disease from 
marijuana use alone.44 However, marijuana use can trigger schiz-
ophrenia in people who are predisposed to the disease, including 
individuals who have close relatives with schizophrenia, given 
 
39. See The Good, Bad, and Unknown About Marijuana’s Health Effects, CBS, 
https://www.cbsnews.com/news/marijuanas-health-effects-good-bad-
unknown (last updated Jan. 12, 2017). 
40. See The Health Effects of Cannabis and Cannabinoids: The Current State 
of Evidence and Recommendations for Research, THE NAT’L ACAD. OF SCI., 
ENGINEERING, AND MED. 19 (2017). 
41. See id. 
42. See id. at 125. 
43. See Casadio et al., supra note 3, at 1783. 
44. Marijuana and Mental Illness, THE NAT’L ALLIANCE ON MENTAL ILLNESS 
(Mar. 2013), https://www.ninthdistrictpta.org/wp-content/uploads/2016/
08/marijuana_factsheet__-NAMI.pdf; see also Andréasson et al., supra 
note 3, at 1483; and see Eggan et al., supra note 3. 
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schizophrenia’s strong genetic link.45 In this population, marijuana 
users are diagnosed with schizophrenia at a younger age, hospitalized 
more often for their illness, and are less likely to completely recover 
from the disease, even with high-quality treatment.46 Those indi-
viduals predisposed to schizophrenia are four times more likely to 
develop the disease after using marijuana.47 
While approximately three percent of marijuana users develop 
schizophrenia, proper marijuana regulations can significantly decrease 
the disease’s emergence by making it more difficult for the individuals 
predisposed to schizophrenia to obtain marijuana.48 Risk factors for 
developing schizophrenia include heavy marijuana use at a young 
age,49 genetic vulnerability, and emotional stress, with marijuana 
acting as a component cause of psychosis.50 Although the approximate 
three percent of marijuana users who develop schizophrenia may seem 
small in comparison to the rest of the population, protecting these 
individuals is crucial because the symptoms of schizophrenia are 
debilitating and may even affect others. 
b. Criticism of the Studies 
Studies finding a connection between marijuana use and schiz-
ophrenia development have met occasional criticism.51 Conflicting 
articles claim there is a link between the two not because marijuana 
 
45. Marijuana and Mental Illness, supra note 44; see also Mader, supra note 36. 
46. Marijuana and Mental Illness, supra note 44. 
47. See Cecile Henquet et al., Prospective Cohort Study of Cannabis Use, 
Predisposition for Psychosis, and Psychotic Symptoms in Young People, 330 
THE BMJ 1, 2 (Dec. 30, 2004). If an individual’s relative is diagnosed with 
schizophrenia, the individual has a ten percent chance of developing 
schizophrenia, instead of the typical one percent chance of developing the 
disease. However, if an individual has an identical twin with the disorder, 
the risk of developing schizophrenia is increased forty to sixty-five percent. 
Paula Mejia, Schizophrenia is Actually Eight Distinct Genetic Disorders: 
New Study, NEWSWEEK (Sept. 8, 2014), http://www.newswee
k.com/schizophrenia-actually-eight-distinct-genetic-disorders-according-new-
study-271407.  
48. Basu & Parakh, Cannabis and Psychosis: Have We Found the Missing 
Link?, 6 ASIAN J. OF PSYCHIATRY 281, 281–87 (2013). 
49. See Jason Rehel, Marijuana Use by Teens Linked to Permanent Brain 
Abnormalities Later in Life, NAT’L. POST (July 25, 2013), http://news.natio
nalpost.com/2013/07/25/marijuana-use-by-teens-linked-to-permanent-brain-
abnormalities-later-in-life-u-s-study/#__federated=1; Marijuana and Mental 
Illness, supra note 44. 
50. Schizophrenia In-Depth Report, supra note 30. 
51. See Maia Szalavitz, The Link Between Marijuana and Schizophrenia, TIME 
(Feb. 7, 2011), http://content.time.com/time/health/article/0,8599,2005559-
1,00.html. 
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causes schizophrenia, but because those with a genetic susceptibility 
to schizophrenia are more likely to use marijuana.52 These articles 
explain that schizophrenia rates have not escalated even though 
marijuana usage has expanded over the past fifty years.53 The articles 
argue that if marijuana increased the chance of manifesting 
schizophrenia symptoms, the percentage of people exhibiting schiz-
ophrenia symptoms would have increased proportionally to the 
percentage of marijuana use.54 According to critics, the lack of this 
correlation undermines the conclusion that marijuana use increases 
the likelihood of developing schizophrenia.55 
A few studies that support the connection between marijuana use 
and schizophrenia argue that this stagnation is due to other factors, 
such as improvements in prenatal nutrition and healthcare that help 
lower the disease’s prevalence rate.56 These studies also explain that 
the stagnant rate of schizophrenia diagnoses is because of the 
improved accuracy of medical diagnoses in recent years.57 For in-
stance, many people previously incorrectly diagnosed with schiz-
ophrenia are now diagnosed with other illnesses, such as Asperger’s 
syndrome or bipolar disorder.58 
c. Literature Review of the Studies and Solutions 
A literature review completed in 2014 synthesized data from 
twenty-nine studies that have explored the possibility of a connection 
between marijuana use and schizophrenia development.59 The authors 
of this review conducted a systematic survey of the literature by 
identifying all articles that reported cross-sectional data on schiz-
ophrenia and marijuana use.60 The authors also contacted experts in 
the field to ask if they knew of other studies that the authors could 
not identify by searching the PubMed and PsychInfo databases.61 
When available data in the articles proved insufficient, the literature 
 
52. Robert A. Powers et al., Genetic Predisposition to Schizophrenia Associated 
with Increased Use of Cannabis, 12 MOL. PSYCHIATRY 1201, 1204 (2014). 
53. Mader, supra note 5. 
54. Id. 
55. Id. 
56. Id. 
57. Id. 
58. See Autism Spectrum Disorder, NAT’L INST. OF MENTAL HEALTH, 
https://www.nimh.nih.gov/health/topics/autism-spectrum-disorders-
asd/index.shtml (last updated Oct. 2016). 
59. Szoke et al., supra note 1, at 58 
60. Id. 
61. Id. at 60. 
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review authors contacted the authors of the individual articles to 
obtain supplementary information.62 Ultimately, the authors obtained 
fifty-three articles, excluding twenty-four of these articles because of 
irrelevance or insufficient information.63 After reviewing the remaining 
studies, the literature review concluded that marijuana use increases 
an individual’s risk of developing schizophrenia if the individual is 
predisposed to the disease.64 The literature review compared the risk 
of developing schizophrenia between subjects that had never used 
marijuana and subjects that had used it at least once and between 
current users and subjects that do not currently use marijuana to 
arrive at this conclusion.65 This review, however, acknowledged the 
need for more research to explore this connection more thoroughly.66 
The majority of studies exploring the possible connection between 
marijuana use and schizophrenia development conclude that mari-
juana use causes schizophrenia and increases its severity in certain 
individuals.67 Therefore, states, and perhaps the federal government, 
should carefully construct restrictions that prevent individuals young-
er than twenty-five and those predisposed to schizophrenia from 
obtaining the drug. For example, if a particular state legalizes mariju-
ana, lawmakers should enact an age limitation of twenty-five before a 
person may legally obtain the drug.68 Moreover, state laws should 
impose additional restrictions on an individual’s ability to access 
marijuana if a physician diagnoses the individual with schizophrenia. 
Imposing an age limitation on the drug and restricting schizophrenics’ 
access to it will considerably decrease many of the psychological 
problems connected to marijuana’s relationship to schizophrenia de-
velopment. An age limitation would also reduce the severity of 
schizophrenia symptoms by restricting marijuana use to those indi-
viduals whose brains are fully developed and have no known predis-
position to developing the disease. 
d. The Necessity of Protecting Three Percent of Marijuana Users 
Because only approximately three percent of people who use 
marijuana develop schizophrenia,69 some people may argue that 
lawmakers should avoid broad policies when seeking to protect such a 
 
62. Id. 
63. Id. 
64. Id. at 58. 
65. Id. 
66. Id. at 65. 
67. Id. at 64; see also sources cited supra note 3. 
68. See infra Section V(a)(iv). 
69. Basu & Parakh, supra note 47, at 281–87. 
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small proportion of the population.70 Schizophrenia, however, is one of 
the costliest mental disorders: the cost for direct treatment of 
schizophrenia is two times higher than the cost of major depression 
and more than four times higher than any anxiety disorder.71 
Schizophrenia is also associated with a high risk of relapse and 
hospitalization, further raising the cost of this disease.72 Some indiv-
iduals with schizophrenia can exhibit dangerous tendencies toward 
themselves and others, including conduct ranging from domestic 
violence to murder.73 Several factors contribute to these dangerous 
tendencies, such as stopping medication, experiencing more severe 
symptoms, or never receiving a proper diagnosis. These effects not 
only result in potentially drastic consequences for individuals but also 
strain law enforcement.74 
The cost of schizophrenia in the United States exceeded $155 
billion in 2013.75 In addition to this immense cost, an individual who 
develops schizophrenia at a younger age is more likely to develop a 
more severe form of the disease.76 Although only a small percentage of 
people develop schizophrenia from marijuana use, this risk often 
occurs during a time of vulnerable brain development, because mariju-
ana use is prevalent among teenagers and young adults.77 Imple-
menting the necessary restrictions on marijuana can help obviate this 
risk.78  
70. Id. 
71. Baojin Zhu et al., Costs of Treating Patients with Schizophrenia Who 
Have Illness-Related Crisis Events, BMC PSYCHIATRY (Aug. 26, 2008), 
http://www.biomedcentral.com/1471-244X/8/72. 
72. See id. 
73. See Jason C. Matejowski et al., Characteristics of Persons with Severe 
Mental Illness Who Have Been Incarcerated for Murder, 36 J. AM. 
ACAD. PSYCHIATRY & L. 74, 74, 80 (2008) (finding that more than fifty 
percent of the offenders also had a history of drug abuse or alcohol 
abuse). 
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health/police-mental-health-training/index.html (last updated Sept. 28, 
2016). 
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nalysisgroup.com/economic-burden-schizophrenia-in-us. 
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this Article will explain why a person who develops schizophrenia at a 
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V. Solutions to Decrease Marijuana’s Negative 
Effects On Schizophrenia’s Development and Severity 
Due to marijuana’s potential harmful effects on schizophrenics or 
those with a predisposition to the disease, lawmakers should come 
prepared with legal policies to address this concern when deciding to 
legalize the drug. These policies should be two-fold: they should pre-
vent all teenagers and young adults from using the drug until their 
physiological and psychological development reaches a certain stage 
and they should restrict individuals diagnosed with the disease from 
possessing the drug altogether. 
a. Imposing an Age Limitation of Twenty-Five on Marijuana Use 
Medical and psychological studies indicate that the human brain 
does not become mature until the age of twenty-five, though some 
variations exist between the genders and some individuals may 
mature slightly faster or slower.79 Perhaps fittingly, schizophrenia be-
comes less prevalent once an individual reaches this age without 
showing major symptoms.80 Even if the individual subsequently 
develops schizophrenia, his or her symptoms are far less severe than a 
person who develops symptoms at an earlier age.81 In addition, mari-
juana’s effects on the brain also diminish once the brain reaches 
maturity.82 Thus, legislators can draw a bright line concerning 
marijuana consumption at the age of twenty-five, unless the indi-
vidual can obtain clearance from a psychologist that he or she has 
little-to-no risk of developing schizophrenia from marijuana. 
i. A Person Under Age Twenty-Five Who Uses Marijuana is More 
Likely to Develop Schizophrenia 
Over the past few years, the world has experienced a twenty-fold 
increase in first time marijuana use in people under the age of 
eighteen.83 This increase is alarming when viewed through the lens of 
schizophrenia development: marijuana use during adolescence creates 
 
79. See Kelly Fleming, What Smoking Weed Does to Teen Brains, THE 
STRANGER (Oct. 22, 2014), http://www.thestranger.com/seattle/what-
smoking-weed-does-to-teen-brains/Content?oid=20884581; Rehel, supra 
note 49. 
80. What is Schizophrenia, supra note 24; Rehel, supra note 49. 
81. See Lynn DeLisi, The Significance of Age of Onset for Schizophrenia, 18 
SCHIZOPHRENIA BULL. 209 (1992); see also Folsom et al., Schizophrenia in 
Late Life: Emerging Issues., 8 DIALOGUES CLINICAL NEUROSCI. 45, 46 
(2006). 
82. See Rehel, supra note 49. 
83. Paolo Casadio et al., Cannabis Use in Young People: The Risk for 
Schizophrenia, 35 NEUROSCIENCE & BEHAVIORAL REV. 1779, 1780 (2011). 
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a particularly high risk of developing schizophrenia because the drug 
causes structural and functional changes to still-developing brains.84 
Marijuana also impairs adolescents’ memory and ability to process 
information.85 Furthermore, an estimated seventeen percent of ado-
lescents become addicted to marijuana, as compared to only nine 
percent of adults.86 Therefore, imposing an age limitation of twenty-
five on marijuana use should help reduce schizophrenia’s development. 
Those who use marijuana at an early age place themselves at a 
higher risk of developing schizophrenia because the brain is more 
vulnerable at a young age.87 Most of the studies find that the younger 
a person is when he or she starts using marijuana, the higher the 
person’s risk for developing schizophrenia because the brain is still 
developing.88 For instance, an adolescent has an increased risk of 
developing schizophrenia if he or she uses marijuana before reaching 
the age of sixteen than if he or she starts using the drug after the age 
of sixteen.89 These results did not analyze the lifetime frequency of 
marijuana use, but marijuana use before age eighteen is especially 
problematic.90 
In addition, the risk of developing schizophrenia strongly correl-
ates with the number of times an individual uses the drug before age 
eighteen.91 Specifically, the risk of developing schizophrenia is 130 
percent higher for individuals who use marijuana between one and ten 
times, 200 percent higher for those who use marijuana between ten 
and fifty times, and 600 percent higher for those who use marijuana 
more than fifty times.92 Additionally, a person is almost five times 
more likely to develop schizophrenia by the age of twenty-six if he or 
she regularly uses marijuana at the age of fifteen.93 These conclusions 
take into account any psychotic symptoms preceding marijuana use 
 
84. See Sheff, supra note 17. 
85. Id. 
86. Marijuana Facts for Teens, NAT’L. INSTI. ON DRUG ABUSE (July 2013), 
https://www.drugabuse.gov/sites/default/files/teens_brochure_2013.pdf. 
87. Casadio et al., supra note 3, at 1783. 
88. See Evins 2013, supra note 3, at e8. 
89. See N.C. Stefanis et al., Early Adolescent Cannabis Exposure and Positive 
and Negative Dimensions of Psychosis, 99 SOC’Y. FOR THE STUDY OF 
ADDICTION 1333, 1337 (2004). 
90. Korver et al., supra note 3. 
91. See Witton, supra note 3, at 129. 
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93. See Louise Arseneault et al., Cannabis use in adolescence and risk for adult 
psychosis: longitudinal prospective study, 325 BRIT. J. OF MED. 1212, 1212 
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and control for other factors.94 Between eight and thirteen percent of 
all schizophrenia cases are connected to using marijuana during teen 
years.95 Specifically, “[e]arly, heavy cannabis use seems to be assoc-
iated with the greatest risk for developing schizophrenia.”96 These 
results are significant because the younger a person is when he or she 
develops schizophrenia, the more severe his or her illness and the 
more difficult the recovery is likely to be.97 
ii. Effects of Marijuana on Brain Development in People Under 
Twenty-Five 
A teenager who uses marijuana develops abnormal changes in his 
or her brain structure more often than a teenager who does not use 
the drug.98 These abnormalities continue to exist many years after the 
individual ceases consuming marijuana.99 This research indicates that 
the drug causes long-term effects when a person starts to use it at a 
young age.100 The brain abnormalities that occur in these teenagers 
are very similar to schizophrenia-related brain abnormalities.101 The 
younger a person is when he or she uses marijuana, the more abnor-
mally his or her brain regions are shaped, demonstrating that the 
brain is more susceptible to marijuana’s negative effects if an indi-
vidual uses the drug at an early age.102 In this specific study, ninety 
percent of the marijuana users who developed schizophrenia started to 
use marijuana heavily prior to developing the disease.103 
Marijuana use before the age of twenty-five presents a particular 
danger because the brain is still forming during the teenage and 
young-adult years.104 Tissue is continuing to “develop . . . connections 
between brain regions and produc[e] the cells that process 
 
94. Id. 
95. Marijuana/Cannabis and Schizophrenia, SCHIZOPHRENIA.COM, http://ww
w.schizophrenia.com/prevention/streetdrugs.html (last visited Sept. 28, 
2017). 
96. Evins 2012, supra note 3, at 1465. 
97. See Cannabis and Psychosis, BRIT. COLUMBIA SCHIZOPHRENIA SOC’Y., 
http://www.heretohelp.bc.ca/sites/default/files/cannabis-marijuana-and-
psychosis.pdf (last visited Sept. 29, 2017). 
98. See Marla Paul, Teen Marijuana Use Linked with Schizophrenia, FUTURITY 
(Jan. 3, 2014), http://www.futurity.org/teen-marijuana-abuse. 
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information. Neurodevelopment is particularly active during childhood 
and adolescence and continues until at least age 25.”105 The frontal 
cortex, which is the area of the brain that controls planning and 
impulses, develops last.106 Unfortunately, the frontal cortex is also the 
area most affected by schizophrenia.107 
Using marijuana while the brain is still developing can cause a 
substantial and negative impact on brain structure volume and the 
quality of white matter: a cause of schizophrenia.108 Brain structure 
volume and the quality of white matter mature during adolescence 
through young adulthood and affect learning and brain functions.109 In 
addition, researchers believe that using marijuana while the brain is 
still developing “boosts levels of dopamine in the brain, which may 
lead directly to schizophrenia.”110 The brain is less vulnerable to these 
negative effects after it has finished developing.111 As a result, mari-
juana legislation should include a national age limitation of twenty-
five before a person may legally use the drug—rather than an age 
limitation of twenty-one, where many jurisdictions have currently set 
it—unless the individual acquires certification from a medical 
professional that he or she exhibits no signs that marijuana use will 
lead to schizophrenia.112 This age limitation should help decrease 
marijuana’s negative psychological effects. 
iii. Detrimental Effects of an Earlier Age of Schizophrenia Onset 
A recent study found that marijuana users developed schiz-
ophrenia almost three years earlier than those who did not use the 
drug.113 This study provides evidence of a strong relationship between 
marijuana use and an earlier age of schizophrenia onset.114 These 
results are concerning because the age of onset appears to be related 
to the severity of the disease and a more negative prognosis for 
subsequent escalation.115 Imposing an age limitation of twenty-five on  
105. Fleming, supra note 79. 
106. Rehel, supra note 49. 
107. Id. 
108. Id. 
109. Id. 
110. Marijuana/Cannabis and Schizophrenia, supra note 94. 
111. See Rehel, supra note 49. 
112. See generally Medical Marijuana Laws by State, FINDLAW (2017), http://
healthcare.findlaw.com/patient-rights/medical-marijuana-laws-by-
state.html. 
113. Szalavitz, supra note 51. 
114. Id. 
115. Schizophrenia In-Depth Report, supra note 30. 
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a person’s ability to access marijuana should help delay schizophren-
ia’s onset. 
There are many benefits to delaying schizophrenia’s onset age, 
since generally, the earlier that schizophrenia develops, the more 
severe the disease and the worse the prognosis.116 According to a 
recent study, an individual with earlier-onset schizophrenia experi-
ences more intense cognitive defects, while individuals who develop 
the disease later have “relatively preserved cognitive functions.”117 In a 
study of hospitalized schizophrenic patients, those who developed 
schizophrenia at an age below the median onset age were more likely 
to show cognitive impairments, negative symptoms, and behavioral 
deterioration than those who developed schizophrenia at an age above 
the median (twenty-five for males and twenty-eight for females).118 
Patients diagnosed with schizophrenia at an older age also exhibited 
fewer and less severe positive symptoms and required lower daily 
doses of antipsychotic medications.119 Moreover, schizophrenia in a 
person under age thirteen is approximately twenty to thirty times 
more severe than adult-onset schizophrenia.120 A neurologist at the 
National Institute of Mental Health estimated that these individuals 
actively hallucinate ninety-five percent of the time they are awake.121 
Additionally, another study showed that an earlier age of 
schizophrenia onset is strongly connected with increased impairment 
of activities involving motor and language skills, which are functions 
controlled by the frontal, temporal, and subcortical regions of the 
brain.122 An earlier age of onset is further associated with impairment 
of verbal learning and memory.123 The ventricular size of the brain 
also increases with an earlier age of onset.124 This fact is significant 
because studies have shown that greater ventricular size predicts a 
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poorer outcome for schizophrenics in terms of the disease’s severity 
and a person’s recovery.125 
iv. Strategies to Help Prevent People Under Age Twenty-Five from 
Obtaining Marijuana 
 
In Colorado and Washington, the marijuana industry currently 
targets children and teenagers with edible and colorful products, such 
as Pot Tarts, Ring Pots, and coupons for marijuana products.126 This 
type of packaging is designed to appeal to youth.127 The marijuana 
industry’s intention seems similar to the tobacco industry’s “once-
secret campaign aimed at youth, attempting to get teens addicted to 
marijuana and make them lifelong customers.”128 One argument 
commonly made against legalizing marijuana is that it would facilitate 
adolescents’ ability to obtain the drug.129 This argument, however, 
does not consider countermeasures that governments should imple-
ment alongside the drug’s legalization.130 It is vital that the Drug 
Enforcement Administration punish the marijuana industry’s tar-
geting of children and teenagers. 
Furthermore, education and other preventative strategies should 
accompany legalization. Congress, along with state legislatures, should 
make it a criminal offense to sell marijuana to a person under age 
twenty-five and provide for strict enforcement of the statute.131 
Otherwise, it may be relatively simple for a young person to obtain 
marijuana once legalized, despite the increased risk of schizophrenia 
development that its consumption brings at that age. The savings the 
government would receive from marijuana’s legalization could fund 
these countermeasures.132 
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126. See Judy Benson, Group Urges Wariness Amid Marijuana Push, THE DAY 
(June 18, 2014), http://www.theday.com/article/20140618/NWS01/30
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customers. See e.g., FLA. STAT. 562.011 (2018); FLA. STAT. 877.112 (2018); 
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b. Psychological Clearance as an Alternative to Use Marijuana 
Some may argue that imposing a restriction on marijuana use for 
anyone under the age of twenty-five may be overly broad despite the 
potential benefit of preventing schizophrenia onset in some 
individuals. The majority of the population would not necessarily 
benefit from an age restriction as far as schizophrenia is concerned.133 
Therefore, state legislatures should consider adopting an additional 
measure to balance the popular support for marijuana’s legalization 
with the state interest of preventing schizophrenia’s onset or mini-
mizing its effects. Rather than enacting a categorical ban on anyone 
under the age of twenty-five using the drug, legislatures should 
consider permitting marijuana use at an earlier age if the person 
receives clearance from a psychologist to do so. 
After thoroughly screening for symptoms indicating that a person 
is at risk for developing the disease, a psychologist could grant 
clearance to an individual under twenty-five. While diagnosing 
schizophrenia may be quite difficult, especially when it comes to a 
single psychological evaluation, the process can have several positive 
outcomes. For most of the population wishing to use marijuana before 
their twenty-fifth birthday, the evaluation would clear them of any 
risk factors for schizophrenia and allow them to purchase the drug. If 
nothing else, the evaluation would allow medical professionals to 
screen for a disease that often goes undiagnosed for years.134 
For patients who show signs of schizophrenia or exhibit the 
potential to develop the disease in the future, the evaluation would 
give them notice to avoid marijuana use altogether. In addition, the 
evaluation could incentivize a patient to seek further diagnoses to 
determine whether he or she has schizophrenia or another mental 
disorder that sometimes presents with similar symptoms.135 At this 
point, the evaluating psychologist should avoid granting clearance for 
marijuana use until the psychologist determines that the patient does 
not possess either schizophrenia proclivities that place the patient at 
risk for developing the disease in the future or another illness that 
marijuana use could exacerbate. Once the psychologist makes these 
determinations to a reasonable degree of confidence, the psychologist 
could clear the patient for marijuana use. 
 
133. Basu & Parakh, supra note 48, at 281–87. 
134. See How is Schizophrenia Diagnosed? LIVING WITH SCHIZOPHRENIA, 
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https://www.webmd.com/schizophrenia/other-conditions-with-symptoms-
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No simple scan or blood test will enable psychologists to diagnose 
schizophrenia.136 Rather, these specialists will rely on diagnostic inter-
views conducted between the patient and the psychiatrist.137 The 
psychiatrist should check the patient’s mental status by observing the 
patient’s appearance and demeanor.138 The psychiatrist should also 
ask about the patient’s moods, hallucinations, delusions, and sub-
stance use and ask whether the patient is experiencing violent or 
suicidal thoughts.139 
For many years, the criteria that psychologists used to diagnose 
schizophrenia were very fluid.140 This led to many misdiagnoses.141 
Over the last two decades, however, recently developed diagnostic 
tools have become precise enough to reduce misdiagnoses, although 
misdiagnoses occur in approximately ten percent of cases.142 “In 
addition to asking a structured series of questions aimed at finding 
out how the patient is thinking,” the psychiatrist should also consider 
other background information, such as family and personal history.143 
Most psychologists today use the Diagnostic and Statistical 
Manual to diagnose schizophrenia.144 The Manual considers four main 
types of symptoms when determining whether an individual presents 
with schizophrenia: delusions, hallucinations, thought disorders, and 
negative symptoms such as apathy or withdrawal.145 Because mental 
disorders can be complex, the psychologist may make an initial 
diagnosis, called a working diagnosis, which the psychologist may 
later change when the psychologist is more familiar with the 
patient.146 The following are all features that the psychologist should 
note: 
Withdrawal: Has the person become withdrawn from friends 
and family? Does he or she spend all day in his or her room and 
refuse to spend time with the family? 
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Strange ideas: Has the person expressed strange ideas about 
being spied on or persecuted? Has the individual developed 
strange religious ideas or ideas about aliens? Does he or she 
relate things that happen in the world news to himself or 
herself? 
Risky behaviors: Has the person started to drive dangerously 
or started to harm himself or herself? Has the individual become 
sexually disinhibited? Did the subject have any recent 
altercations with the police? 
Emotional Responses: Does the person appear afraid or 
agitated for no reason? Do the individual’s responses appear 
blunted emotionally or paradoxical (appearing happy when 
something bad happens and sad when something good 
happens)? 
Changes in activity: Has the person given up studying or 
work for no apparent reason? Does the subject stay up at night 
and then sleep during the day? Has the individual started to 
attend church frequently or spend lots of time shopping? Has he 
or she been spending lots of money on things he or she does not 
need? 
Performance: Has the subject’s performance at work or college 
suddenly declined? Has the person become lax with personal 
hygiene or obsessive about it? Has he or she become very 
forgetful? Does the individual forget about appointments and 
arrangements he or she has made? 
A psychologist will diagnose a patient with schizophrenia upon 
meeting four conditions: (1) the person must have at least one clear 
symptom that is characteristic of schizophrenia, such as hearing 
voices; (2) the symptom(s) must have been present for at least one 
month and the disturbances to the individual’s life must have been 
evident for at least six months; (3) the symptoms must be impacting 
on the person’s social functioning or their occupation, such as 
employment or studying; and (4) other conditions that may cause the 
symptom, such as use of street drugs, can be ruled out.147 
c. Restricting Marijuana Use by Schizophrenics 
Lawmakers can reduce schizophrenia’s negative effects by res-
tricting schizophrenics or individuals who are predisposed to schiz-
ophrenia from using the drug and by imposing general age restrictions 
on its use. Numerous studies have shown that marijuana not only 
exacerbates the symptoms of this disease but also interferes with 
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effective treatment.148 Since schizophrenia often affects more than the 
patient—such as the patient’s caretakers or individuals who are 
harmed if the patient becomes violent149—legislators across the coun-
try should consider limiting schizophrenics’ access to the drug. While 
a patient may not necessarily resort to violent action because of mari-
juana use, THC may harm a patient who is trying to combat 
schizophrenia.150 These additional effects outweigh whatever benefits 
an individual may gain from consuming marijuana. 
i. Symptom Exacerbation in Schizophrenics Who Use Marijuana 
Since the 1970s, scientists have known that marijuana can harm 
schizophrenics. In 1978, one of the first studies explaining marijuana’s 
negative effects on those diagnosed with schizophrenia demonstrated 
that marijuana use as an independent variable produced a “serious 
exacerbation” of psychosis in schizophrenics whose illness was well 
controlled with antipsychotic medication.151 Every time each subject 
used marijuana, the individual experienced exacerbation and deter-
ioration of his or her condition.152 This reaction is consistent with the 
conclusion that schizophrenics are more likely to experience negative 
emotions when using marijuana, including depression, anxiety, or 
paranoia.153 Marijuana’s interaction with certain chemicals in the brain, 
including dopamine, causes these emotions.154 
A recent study further determined that schizophrenics who use 
marijuana are more likely to suffer problems such as negative family 
relationships, increased crime and violence, and escalating isolation.155 
Schizophrenics who use marijuana also experience more trouble with 
memory tests compared to schizophrenics who abstain from the 
drug156 In addition, schizophrenics who use marijuana are more likely 
than other schizophrenics to skip their treatments, including antipsy-
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chotic medication and behavioral therapy, which could result in fur-
ther exacerbation of symptoms.157 
Marijuana use increases a schizophrenic’s relapse rate and causes 
an individual to suffer more profoundly from visual hallucinations.158 
Hours after a schizophrenic uses marijuana, his or her hallucinations 
become much worse.159 Doctors at Yale University tested the impact 
of marijuana on 150 healthy volunteers and thirteen people with 
stable schizophrenia.160 The doctors originally expected to see mari-
juana improve the schizophrenics’ conditions, as many of these 
patients reported that marijuana decreased their anxiety.161 However, 
the reverse was true.162 The doctors intended to study marijuana’s 
impact on more schizophrenic patients, but the doctors had to stop 
the study “prematurely because the impact was so pronounced it 
would have been unethical to test it on more people with schiz-
ophrenia.”163 This study underscores the drug’s negative impact on 
individuals exhibiting schizophrenia symptoms. 
Marijuana use in schizophrenics also causes symptom exacerbation 
and increased hospitalizations.164 Schizophrenics who use marijuana 
experience a loss of brain volume that is significantly greater than 
schizophrenics who do not use the drug.165 This loss can aggravate 
schizophrenia by increasing the severity and frequency of the indi-
vidual’s symptoms.166 It is common for a schizophrenic to experience a 
psychotic episode after he or she uses marijuana.167 Symptom exacer-
bation results from marijuana’s effect on a schizophrenic’s levels of 
the neurotransmitter anandamide.168 Studies have shown that people 
with higher levels of anandamide experience fewer psychotic sym- 
157. See Drug Abuse and Schizophrenia, ELEMENTS BEHAVIORAL HEALTH (Feb. 
14, 2013), http://www.elementsbehavioralhealth.com/dual-diagnosis/drug-
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ptoms.169 Marijuana use, however, decreases levels of anandamide, 
which explains why schizophrenics experience worsening symptoms 
after using marijuana.170 According to a recent study, “frequent and 
intense cannabis smoking [reduces] an endogenous protective mech-
anism, mediated by anandamide, resulting in an increased risk for 
precipitation of psychosis.”171 These findings make it even more 
imperative that access to marijuana is restricted for individuals with 
schizophrenia or at risk of developing the disease. 
ii. Marijuana’s Harmful Effects on Antipsychotic Medications 
 Marijuana use decreases the benefits of antipsychotic medications 
used to treat schizophrenia.172 Marijuana may also harmfully interact 
with these medications, leading to dangerous side effects such as 
difficulty breathing.173 Higher doses of antipsychotic medications cause 
more side effects and a higher risk of relapse.174 Physicians generally 
use two drug classes to help treat schizophrenia. These classes include 
typical antipsychotic medications, such as haloperidol, chlor-
promazine, and perphenazine.175 There are also atypical antipsychotic 
medications, such as clozapine, risperidone, and aripiprazole.176 These 
antipsychotic medications help treat schizophrenia’s hallucinations 
and delusions.177 Marijuana use exacerbates hallucinations and 
delusions associated with schizophrenia and prevents the medication 
from helping.178 
Additionally, a person is more likely to experience side effects, 
such as hypotension, when consuming marijuana and antipsychotic 
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174. Tabea Schoeler et al., Association Between Continued Cannabis Use and 
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(2016). 
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medications concurrently.179 Combining marijuana with antipsychotic 
medications causes a “moderate interaction” that increases side effects 
such as dizziness, drowsiness, and difficulty concentrating.180 Some 
people also experience impaired thinking and judgment.181 Other 
effects of combining marijuana and antipsychotic medications include 
misunderstanding the patient’s mental condition and response to the 
therapy and an increase in psychosis.182 A 2003 study in Britain 
studied rats that were administered haloperidol and injected with 
marijuana.183 The rats exhibited ataxia, catalepsy, and immobility.184 
Although it is uncertain whether these side effects would extend to 
humans, the study demonstrates that an individual may suffer serious 
side effects when combining marijuana and antipsychotic medications. 
d. Enforcement 
The above scientific findings demonstrate that individuals under 
the age of twenty-five should avoid using marijuana unless cleared by 
a psychologist. Further, individuals of all ages with proclivities for 
developing schizophrenia or those already suffering from the disease 
should avoid using marijuana altogether.185 These individuals may 
constitute a minority of prospective marijuana users, but their pro-
tection still presents an important government interest. Thus, a 
jurisdiction contemplating marijuana legalization should implement 
adequate enforcement measures that would at least partially prevent 
at-risk individuals from obtaining and using marijuana. 
While enforcing laws that restrict certain individuals’ ability to 
use marijuana will undoubtedly be difficult, such difficulty is no 
reason to avoid the necessary regulation. After all, the fact that 
individuals might break the law is no reason to avoid passing it. Per-
haps the most effective way to ensure that unauthorized individuals 
do not access the drug is to require documentation that demonstrates 
 
179. Caroline P. O’Grady & W.J. Wayne Skinner, A Family Guide to 
Concurrent Disorders, CTR. FOR ADDICTION AND MENTAL HEALTH 151 
(2007), available at http://www.camh.ca/en/hospital/health_informatio
n/a_z_mental_health_and_addiction_information/concurrent_disorders/
a_family_guide_to_concurrent_disorders/treatment/Pages/drug_interacti
ons.aspx. 
180. Drug Interaction Report, supra note 173. 
181. Id. 
182. See Learn About Marijuana, U. WASH.: ALCOHOL & DRUG ABUSE INST. 
(2016), http://learnaboutmarijuanawa.org/factsheets/medications.htm. 
183. Casti et al., Haloperidol, but not Clozapine, Produces Dramatic Catalepsy 
in THC-Treated Rats, 140 BRIT. J. PHARMACOLOGY 520, 520–26 (2003). 
184. Id. 
185. Minkel, supra note 148; Szalavitz, surpa note 51. 
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the person is authorized to make the purchase at the cash register, 
similar to the documentation required to purchase alcohol and 
tobacco products. When purchasing marijuana, a state could require a 
person to show documentation that he or she is an eligible purchaser 
of the drug. Documentation demonstrating eligibility could consist of 
something as simple as a symbol on a driver’s license. The individual 
could request that symbol when he or she renews the license upon 
reaching the age of twenty-five or showing adequate proof that a psy-
chologist has cleared him or her to use the drug prior to the age of 
twenty-five.186 
Critics may argue that the proposed psychological evaluations and 
the requirement for documentation to purchase marijuana may suffer 
from a low success rate. For example, critics may point out that 
similar age restrictions currently exist to prevent youth from obtain-
ing alcohol and tobacco products,187 but young people frequently do so 
anyway by simply obtaining these products from people who have 
authorization to buy these products.188 Critics may also point out that 
governments experienced significant problems reducing marijuana use 
across the nation when the drug was entirely illegal. Curtailing 
marijuana use in a jurisdiction where the drug is legalized would 
present even more difficulty. 
While difficulties will persist in restricting access to cannabis from 
unauthorized users of the drug, these approaches would be beneficial 
in important ways. First, at least some individuals would avoid 
violating the law to avoid punitive measures.189 Second, others wishing 
to comply with the psychological evaluation requirement would 
receive an evaluation that would lead to the potential diagnosis of 
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should not be construed to show that the individual suffers from any type of 
mental illness. After all, the lack of the symbol can mean many things, 
including the fact that the person has no intention of smoking marijuana or 
has chosen not to be evaluated by a psychologist prior to the age of twenty-
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they-dont-drink-alcohol/ (demonstrating that one of the top five reasons 
that teenagers avoid drinking is because of its illegality). 
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schizophrenia that may otherwise go untreated. This evaluation would 
advance the government interest of ensuring that citizens who show 
risk factors for schizophrenia receive early diagnosis and treatment. 
Finally, while individuals who are diagnosed with schizophrenia could 
circumvent the law by purchasing marijuana from illegal sources, they 
would have a strong incentive to avoid such conduct. Their disin-
centive would result from the conduct’s illegality and the information 
that psychologists would provide to them concerning the dangers of 
consuming marijuana if diagnosed with schizophrenia. While passing a 
law and successfully enforcing it remain two very distinct actions, the 
fact that some individuals may ignore limitations on marijuana use 
does not reduce the benefits of these limitations to others. 
VI. Conclusion 
Marijuana causes negative effects on the brain that may increase 
a person’s risk of developing schizophrenia. However, legalizing 
marijuana has potential benefits, such as increasing government 
revenue, decreasing violence, and providing relief for certain medical 
conditions. When a state legalizes marijuana, it should develop safe-
guards to ensure that people under the age of twenty-five cannot 
obtain the drug. Additionally, state and federal lawmakers should 
take steps to restrict schizophrenics’ access to the drug. Implementing 
these safeguards will decrease marijuana’s negative effects on the 
development and severity of schizophrenia, and that will improve 
society. 
